Bids Are Invited For Central Purchase - Medicines Judicial Service I

Abiraterone - Active Principle: Abiraterone, Acetate; Concentration/Dosage: 500 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Componis, Aceclofenac - Active Principle: Aceclofenac; Concentration/Dosage: 100 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Component:.; Concentration/Dosage: 81 Mg; Pharmaceutical Form: Liberation Coated Tablet And, Tioctic Acid - Active Principle: Tioctic Acid; Concentration/Dosage: 600 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Component:, Alpha-1-Antitripsin-Active Principle: Alpha-Antitripsin; Concentration/Dosage: 1,000 Mg; Pharmaceutical Form: Poi Lyophilized For Injectable Solution; Concentration/Dosage: 50 Mg; Pharmaceutical Form: Po For Concentrate For Perfu Solution, Alprazolam - Active Principle: Alprazolam; Concentration/Dosage: 2 Mg; Pharmaceutical Form: Tablet; Presentation: .; Component:.; Concentration/Dosage: 200 Mg; Pharmaceutical Form: Tablet; Presentation: .; Component:.; Concentration/Dosage: 50 Mg; Pharmaceutical Form: Tablet; Presentation: .; Component: .; Anagrelida - Active Principle: Anagrelida, Hydrochloride; Concentration/Dosage: 0, 5 Mg; Pharmaceutical Form: Hard Gelatinous Capsule; Presentation: .; Comp, Aripiprazol - Active Principle: Aripiprazol; Concentration/Dosage: 1 Mg/Ml; Pharmaceutical Form: Oral Suspension; Presentation: 100 Ml Bottle; Component, Arypiprazole - Active Principle: Aripiprazol; Concentration/Dosage: 20 Mg/Ml; Pharmaceutical Form: Oral Suspension; Presentation: Bottle; Component: .; Aripiprazol - Active Principle: Aripiprazol; Concentration/Dosage: 30 Mg; Pharmaceutical Form: Tablet; Presentation: .; Component: .; Benfotiamine - Active Principle: Benfotiamine; Concentration/Dosage: 150 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Component:.; Concentration/Dosage: 0, 1 Mg/Ml; Pharmaceutical Form: Ophthalmic Solution; Presentation: 3 Ml Bottle; Compo, Bimatoprost + Associations - Active Principle (1): Bimatoprost; Active Principle (2): Timolol, Maleato; Concentration/Dosage: 0, 3 Mg/Ml + 5 Mg/Ml; Form, Maleato + Brimonidina, Tartarato; Concentration/Dosage: 0 ,, Bisoprolol - Active Principle: Bisoprolol, Hemifumarato; Concentration/Dosage: 2, 5 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Compoo, Hemifumarate; Concentration/Dosage: 5 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Componone, Briminidina - Active Principle: Briminidina, Dextratartarato; Concentration/Dosage: 1 Mg/Ml; Pharmaceutical Form: Ophthalmic Solution; Presentation: Frasc, Briminidina + Associations - Active Principle (1): Brimonidina, Dextratartarato; Active Principle (2): Timolol, Maleato; Concentration/Dosage: 2 Mg/Ml +, Bromazepam - Active Principle: Bromazepam; Concentration/Dosage: 6 Mg; Pharmaceutical Form: Tablet; Presentation: .; Component:.; Concentration/Dosage: 10 Mg; Pharmaceutical Form: Transdermal Adhesive; Presentation: Envelope; Component, Bupranorphine - Active Principle: Bupranorfine; Concentration/Dosage: 20 Mg; Pharmaceutical Form: Transdermal Adhesive; Presentation: Envelope; Component, Bupranorphine - Active Principle: Bupranorfine; Concentracha